Results 141 to 150 of about 31,170 (214)

Comparative efficacy and safety of dual-combination vs. triple-combination antihypertensive therapies in hypertensive patients: an updated meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Gong Z, Huang L, Long X, Zhang Y.
europepmc   +1 more source

Angiotensin II prevents the metabolic but not the transdifferentiating effect of EGF on vascular smooth muscle cells from human female donors. [PDF]

iScience
Dubourg V, Akhtar N, Kopf M, Spilker A, Mildenberger S, Schreier B, Schwerdt G, Biemann R, Benndorf RA, Gekle M.   +9 more
europepmc   +1 more source

Angiotensin II Disrupts Axo-Axonal Interaction-Mediated Vasorelaxation in Basilar Arteries of Normotensive and Hypertensive Rats. [PDF]

Biomedicines
Yang SS, Chen KY, Fu E, Chang HH, Huang KF.   +4 more
europepmc   +1 more source

Losartan: A Promising Candidate in Cartilage Regeneration

In the process of chondrogenesis, chondroprogenitor stem cells differentiate to chondroblasts and then to chondrocytes. During this procedure, the differentiating cells produce cartilage-specific extracellular matrix (ECM) proteins.
Baik, Jong Heon
core  

Topical losartan to prevent stromal scarring during post-cross-linking infection in pediatric keratoconus: A case report. [PDF]

Am J Ophthalmol Case Rep
Barzaghi F, Kronschläger M, Amir-Asgari S, Findl O.   +3 more
europepmc   +1 more source

Seizures, increased interhemispheric synchrony, altered brain transcriptomics and a leaky blood-brain barrier result from loss of <i>ap3b2</i> in a CRISPR tadpole model of DEE48. [PDF]

Front Neurol
Banerjee S, Earl CW, Robson SC, Szyszka P, Beck CW.   +4 more
europepmc   +1 more source

Drug-Induced Liver Injury Associated With the Angiotensin II Receptor Blocker Losartan in a 59-Year-Old Woman With Hypertension: A Case Report. [PDF]

Am J Case Rep
Al-Ajaj A, Melki W.
europepmc   +1 more source

Effect and safety of Yiqi-Shengjin granules in hypertension management among patients with abnormal glucose metabolism: a study protocol for a randomized, double-blind, placebo-controlled clinical trial. [PDF]

Front Cardiovasc Med
Shi H, Li R, Shang J, Chen Z, Zhao X, Li S, Yang L.   +6 more
europepmc   +1 more source

Losartan, toceranib, and carboplatin combination therapy for progressive pulmonary metastasis in canine osteosarcoma: a case report. [PDF]

Ir Vet J
Kwak JH, Jung M, Choi SN, Jeong KS.
europepmc   +1 more source

From concept to clinical practice: the evolution of low- and ultra-low-dose triple combination therapy for hypertension. [PDF]

Clin Hypertens
Park JS, Sung KC, Rhee MY.
europepmc   +1 more source